Anebulo Pharmaceuticals Inc (ANEB) concluded trading on Wednesday at a closing price of $3.33, with 19.95 million shares of worth about $66.44 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 99.40% during that period and on July 23, 2025 the price saw a gain of about 81.97%. Currently the company’s common shares owned by public are about 41.08M shares, out of which, 24.43M shares are available for trading.
Stock saw a price change of 108.12% in past 5 days and over the past one month there was a price change of 119.08%. Year-to-date (YTD), ANEB shares are showing a performance of 43.53% which increased to 98.21% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.80 but also hit the highest price of $3.08 during that period. The average intraday trading volume for Anebulo Pharmaceuticals Inc shares is 14.44K. The stock is currently trading 92.96% above its 20-day simple moving average (SMA20), while that difference is up 138.64% for SMA50 and it goes to 130.35% higher than SMA200.
Anebulo Pharmaceuticals Inc (NASDAQ: ANEB) currently have 41.08M outstanding shares and institutions hold larger chunk of about 55.05% of that.
The stock has a current market capitalization of $136.82M and its 3Y-monthly beta is at -0.97. It has posted earnings per share of -$0.27 in the same period. It has Quick Ratio of 25.29 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ANEB, volatility over the week remained 12.15% while standing at 15.85% over the month.
Stock’s fiscal year EPS is expected to rise by 10.94% while it is estimated to decrease by -68.42% in next year. EPS is likely to grow at an annualized rate of -12.86% for next 5-years, compared to annual growth of -155.95% made by the stock over the past 5-years.
